Matthew has over 20 years’ experience designing global real-world evidence solutions to support the development and commercialization of pharmaceutical / biotechnology products and devices. His experience covers a wide-range of therapeutic areas, as well as strategic objectives from natural history programs, external control arm studies for regulatory approval, and global safety-surveillance mandate. His technical expertise includes program strategy and operational structure in disease and product registries, prospective pharmacoeconomic studies, and systematic reviews of scientific literature.
Matthew Gordon
